Turner Imaging Systems Announces Closing of Seed Investment Round

For Immediate Release 2/20/18 Orem, Utah -2/20/2018 - Turner Imaging Systems, developer of the Smart-C battery-powered mini C-arm, announced today the successful closing of its seed funding round. The round was completed by Radnet Management, Inc., the principal operating subsidiary of RadNet, Inc. (NASDAQ: RDNT or “RadNet”), with additional participation by Cavendish Impact Capital and private investors. “We are extremely pleased to complete our funding with RadNet, which is a national leader in providing high-quality, fixed-site outpatient diagnostic imaging services,” said…

Continue Reading

Turner Imaging Systems Announces Closing of Seed Investment Round

FOR IMMEDIATE RELEASE 11/20/2017   Turner Imaging Systems Announces Closing of Seed Investment Round Orem, Utah -11/20/2017 - Turner Imaging Systems, developer of the Smart-C battery-powered mini C-arm, announced today the successful closing of its seed funding round. The round was led by venture capital firm Cavendish Impact Capital with participation from other private investors. “We share in Cavendish Impact Capital’s dual mission to provide a financial return to investors and have a positive impact…

Continue Reading

RESI and BioTech Showcase 2017

FOR IMMEDIATE RELEASEJanuary 1, 2017Turner imaging systems to attend RESI and BioTECH SHOWCASE during the J.P. Morgan healthcare conferenceOrem, UT, January 1, 2017– Turner Imaging Systems, an early stage medical device company developing a battery-powered handheld imaging device, announced today that will be attending the RESI and BioTech Showcase during the 35th Annual J.P. Morgan Healthcare Conference from January 9, 2017 to January 12, 2017 at the Westin St. Francis Hotel, 335 Powell Street, San…

Continue Reading

NEW VP of Business Development

FOR IMMEDIATE RELEASENovember 28, 2016Turner Imaging Systems announced today that Ginny Rowland has joined our organization as the VP of Business Development to lead the go to market strategies for our emerging technologies.Ms. Rowland has spent over 30 years in Healthcare Administration, Business Development and Marketing. She has held Executive Leadership roles with the Global Fortune 500 companies and privately owned businesses. Her key expertise is in bringing medical technologies and products to market on a…

Continue Reading
Close Menu